Merlin-YAP signaling: emerging mechanisms, functions, and therapeutic approaches.
The Hippo signaling pathway has a critical role in regulating tissue growth, development, and tumor suppression.
APA
Guo P (2026). Merlin-YAP signaling: emerging mechanisms, functions, and therapeutic approaches.. Trends in cell biology, 36(4), 301-311. https://doi.org/10.1016/j.tcb.2025.09.001
MLA
Guo P. "Merlin-YAP signaling: emerging mechanisms, functions, and therapeutic approaches.." Trends in cell biology, vol. 36, no. 4, 2026, pp. 301-311.
PMID
41125494
Abstract
The Hippo signaling pathway has a critical role in regulating tissue growth, development, and tumor suppression. Mutations in NF2, which encodes the tumor suppressor Merlin, disrupt Hippo signaling, causing aberrant activation of YAP/TAZ and contributing to diseases, such as cancer and developmental disorders. Recent studies have identified novel mechanisms by which biomolecular condensation and phosphoinositides regulate Merlin function in Hippo signaling. Furthermore, NF2 deficiency sensitizes cells to ferroptosis, a form of regulated cell death characterized by iron-dependent lipid peroxidation. In this review, I highlight the emerging roles of Merlin-YAP signaling in physiology and disease, focusing on its regulation through biomolecular condensates, its contribution to development and ferroptosis, and its implications for therapeutic interventions.
MeSH Terms
Humans; Neurofibromin 2; Signal Transduction; Animals; YAP-Signaling Proteins; Transcription Factors; Adaptor Proteins, Signal Transducing; Ferroptosis; Neoplasms
같은 제1저자의 인용 많은 논문 (5)
- Diterpenoids and triterpenoids from the roots of and their inhibitory effects on colorectal cancer cells.
- MFAP2 promotes the malignant progression of gastric cancer via activating the PI3K/AKT signaling pathway.
- Integration of single cell and bulk transcriptomic analyses identifies FAM189A2 as a key prognostic gene in lung cancer.
- The key enzyme PYCR1 in proline metabolism: a dual driver of cancer progression and fibrotic remodeling.
- CircSMEK1 Suppresses HCC via the hnRNPK-IGF2-AKT Axis: A Diagnostic Biomarker and Therapeutic Target.